Germline Testing for Predisposition to Myeloid Malignancies
Germline Testing for Predisposition to Myeloid Malignancies
Recruiting · NCT07112287 · Registry updated 2026-04-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Germline Testing for Predisposition to Myeloid Malignancies | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, disease susceptibility, inherited disease susceptibility, myeloid neoplasm | Recruiting | Not applicable | 2026-04-24 | NCT07112287 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Broad Institute of MIT and Harvard | 12 |
| Christopher Reilly | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana-Farber Cancer Institute | Boston | United States | 626 |